Status report
Get it in writing
The official USPTO status record for FORESITE 360, serial 97676484, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
FORESITE 360Serial 97676484 · Principal Register
Dead · Withdrawn
Owner: Fore Genomics, Inc.
Class 005 - Pharmaceuticals
Filed Nov 14, 2022
The record shows that the mark “FORESITE 360” is dead, having been abandoned by its owner, Fore Genomics, Inc., a Delaware corporation. The abandoned application was filed on November 14, 2022 on the Principal Register under class 005 for a whole‑genome screening test for healthy children. Because the mark is no longer active, it does not give the owner exclusive control over the wording in all contexts, but it does indicate that the owner once sought protection for that specific medical test. The prosecution history shows a normal examination sequence, with an initial application, a voluntary amendment, and an extension of the response period, before the applicant filed an express abandonment on March 12, 2024. No oppositions, cancellations, or court actions appear in the supplied history, so there is no visible enforcement activity. For someone considering a similar name, the closest concern would be in the area of whole‑genome screening tests for children; use in unrelated fields would be farther from the scope of this abandoned mark.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.